Beckman Coulter Announces FDA Clearance Of UniCel(R) DxH 800
Beckman Coulter, Inc. ushers in a new era of cellular analysis with the release of the UniCel(R) DxH 800 Coulter(R) Cellular Analysis System. Capturing 29 individual measurements per cell analyzed, the system provides improved sensitivity and specificity, which means more reliable assessment of abnormal cell populations. Laboratories equipped with the system will be able to respond more quickly and accurately to physician demands, improving patient health and reducing the cost of care. The system’s all new physical design minimizes moving parts, increasing instrument reliability and technologist efficiency.
- Hotspur Technologies Receives FDA 510(k) Clearance For First Three Product Lines Based On its Unique Technology
- Calibra Gains FDA Clearance To Market Finesse(TM) Insulin Patch-Pen For Three-Day Use With Novolog(
- Merit Medical gets FDA approval on torque device
- Sorin Group Announces The Japanese Approval And Market Release Of Defibrillation Lead: Isoline™
